Advertisements

Stocking Stuffers

 

Regeneron Pharmaceuticals Inc. (REGN) Stock Quote

Detailed Quote for Regeneron Pharmaceuticals Inc. (REGN)
$ 420.60   -3.37 (-0.79%) Volume: 397.8k 4:00 PM EST 19-Feb-2019
After Hours:  $ 420.60 0.00 (0.00%) Volume: 12.08k 5:27 PM EST 19-Feb-2019
Today 5d 1m 3m 1y more
Last Price
420.60
Change $
3.37
Change %
0.79%
Tick
  
Bid
412.59
Bid Size
100
Ask
427.75
Ask Size
100
Open
423.74
High
426.41
Low
420.351
Prev Close
423.97
Last Trade
02/19/19
Volume
397.8k
52 Wk Hi
431.320007
52 Wk Low
281.890014
Market Cap
45.96b
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
109,277,189
EPS (TTM)
21.2999992
PE Ratio
19.50
Exchange
NGS
News and Media for Regeneron Pharmaceuticals Inc. (REGN)
Sector News | Topic News
News for Regeneron Pharmaceuticals Inc. (REGN)
Tue, Feb 19, 2019
4:45 AM Teva: Reasons To Avoid It In Favor Of Innovative Biotechs - SeekingAlpha
Sat, Feb 16, 2019
10:34 AM Regeneron and Sanofi prevail in review of Amgen's IL-4 receptor patent - SeekingAlpha
9:00 AM How To Get High Growth With Half The Risk - SeekingAlpha
Fri, Feb 15, 2019
4:42 PM U.S. and EU Patent Office Decisions Invalidate Amgen Subsidiary Immunex's Patents Claiming Antibodies to the IL-4 Receptor - PR Newswire
Thu, Feb 14, 2019
9:30 AM Regeneron Announces Upcoming Investor Conference Presentation - PR Newswire
7:28 AM Alexion's Complementary Growth Strategy - SeekingAlpha
Wed, Feb 13, 2019
2:55 PM Biotech Bonanza: The Mergers And Acquisitions Theme - SeekingAlpha
Tue, Feb 12, 2019
8:30 AM New Research Coverage Highlights Overstock, Regeneron Pharmaceuticals, Molecular Templates, The Ensign Group, Limoneira, and Primo Water - Consolidated Revenues, Company Growth, and Expectations for 2019 - GlobeNewswire
Mon, Feb 11, 2019
9:32 AM Regeneron: Cheap Enough To Look Past The Eylea Valley - SeekingAlpha
7:48 AM Sanofi and Regeneron to cut price of Praluent - SeekingAlpha
7:42 AM Regeneron reports positive data from Phase 3 EYLEA trial in diabetic retinopathy - SeekingAlpha
7:00 AM Sanofi and Regeneron offer Praluent\u00AE (alirocumab) at a new reduced U.S. list price - PR Newswire
6:59 AM Regeneron and Sanofi Offer Praluent\u00AE (alirocumab) at a New Reduced U.S. List Price - PR Newswire
Sat, Feb 09, 2019
4:30 PM One-Year Results from Positive Phase 3 EYLEA Trial in Diabetic Retinopathy Presented at Angiogenesis Symposium - PR Newswire
Thu, Feb 07, 2019
9:55 PM Vertex: Shareholders Might Have Reason To Breathe More Easily - SeekingAlpha
Wed, Feb 06, 2019
1:30 PM Regeneron Pharmaceuticals, Inc. (REGN) CEO Leonard Schleifer on Q4 2018 Results - Earnings Call Transcript - SeekingAlpha
More News for REGN >>
Filings for Regeneron Pharmaceuticals Inc. (REGN)
Thu, Feb 14, 2019
3:00 AM Statement of beneficial ownership of common stock by certain persons - Form SC 13G
Wed, Feb 13, 2019
3:00 AM Amendment to the SC 13G filing - Form SC 13G/A
Mon, Feb 11, 2019
3:00 AM Amendment to the SC 13G filing - Form SC 13G/A
Thu, Feb 07, 2019
3:00 AM Annual report with a comprehensive overview of the company - Form 10-K
More Filings for REGN >>

Tags for Regeneron Pharmaceuticals Inc.

Research stocks or mutual funds related to Regeneron Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to REGN. The keywords below have been associated to REGN by either user submission or electronic means.

life sciences market research biotech research pharmaceuticals research pharmaceuticals international research pharmaceutical branding pharmaceutical market generic pharmaceutical clinical research consulting pharmaceutical research and development pharmaceutical manufacturing company Biological Products pharma marketing pharmaceutical industry marketing pharma industry research pharmaceutical software pharma manufacturing pharma license pfizer pharmaceutical company novartis pharmaceuticals pharmaceutical cro pharma consulting pharmaceutical sales pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical consultant biotech Drugs pharmaceutical industry news pharmaceutical manufacturing software oncology careers pharmaceutical manufacturing pharmaceutical formulation company research pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting pharmaceutical industry pharmaceutical studies patent research pharmaceutical advances pharmaceutical distributor research sales oncology market pharmaceutical out licensing pharmaceutical co promotion merck pharmaceuticals pharmaceutical business development Healthcare